Sobi Acquires Dova in US$915 M Deal
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 10 (Table of Contents)
Published: 9 Oct-2019
DOI: 10.3833/pdr.v2019.i10.2459 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Expanding its haematology portfolio, Swedish Orphan Biovitrum (Sobi) has agreed to acquire Dova Pharmaceuticals for up to US$915 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS